Boehringer Hit with Another Pradaxa Injury Lawsuit

By Sarah Mirando | August 22, 2012

Category: Pharmaceuticals

{loadposition pradaxa_lawsuit}

By Mike Holter

A new lawsuit has been filed against Boehringer Ingelheim Pharmaceuticals alleging the company failed to warn about the risk of Pradaxa side effects. Plaintiff Jose Monebias alleges in the Pradaxa lawsuit that the blood-thinning drug caused him to suffer a severe stroke that left him with permanent injuries, including partial paralysis.

Pradaxa has come under fierce scrutiny lately amid thousands of reports of patients suffering severe uncontrollable bleeding side effects. In 2011 alone, there were nearly 3,000 reports of bleeding injuries linked to Pradaxa. Like all blood-thinning medications, Pradaxa carries the risk of internal bleeding. However, unlike its competitor Warfarin (Coumadin), there is no antidote for Pradaxa bleeding. Hundreds of people have bled to death while using Pradaxa, and many more have suffered severe or permanent injuries from their internal bleeding. As a result, hundreds of Pradaxa injury lawsuits and wrongful death lawsuits have been filed against Boehringer Ingelheim for failing to warn the public that there is no cure for Pradaxa bleeding side effects.

Monebias alleges in his Pradaxa lawsuit that he was prescribed Pradaxa to treat his atrial fibrillation. According to his Pradaxa injury lawyer, neither Monebias nor his doctor were aware that Pradaxa carried the risk of uncontrollable bleeding without an antidote because there was no such warning on the drug’s label. Had they been aware of this risk, they would not have chosen Pradaxa to treat Monebias’ condition, the lawsuit alleges.

Monebias, with the help of his Pradaxa lawyer, is suing Boehringer for actual, treble and punitive damages for his injuries, which he says caused him emotional distress, mental and physical pain, economic loss, and ongoing medical expenses.

Pradaxa Lawsuits Consolidated in MDL

On August 8, 2012, a judicial panel consolidated all pending and future Pradaxa lawsuits into multidistrict litigation (MDL) before U.S. District Judge David R. Herndon. The new Pradaxa lawsuit MDL is good news for Pradaxa bleeding victims hoping to pursue compensation for their injuries because it will streamline the litigation process and hopefully make it easier to secure a Pradaxa lawsuit settlement. A settlement awarded in the Pradaxa MDL could be much more than one obtained through a Pradaxa class action lawsuit settlement. If you are considering filing a lawsuit to pursue compensation from Boehringer, a Pradaxa compensation specialist can help determine which course of legal action will help you obtain the most money for your injuries.

For more information, visit the Pradaxa Internal Bleeding Class Action Lawsuit Investigation. Experienced Pradaxa injury attorneys are standing by, and will provide a free consultation about your case. After reviewing your information, they will advise you on whether a Pradaxa injury lawsuit, Pradaxa class action lawsuit or joining the Pradaxa MDL is best for you and your family.

Updated August 22nd, 2012

{loadposition content_postads}

All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.

LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement

Various Trademarks held by their respective owners.